JAK2 and cyclic hematopoiesis: Although the demographic factors, co-morbidities, and lifestyle factors impacting DNMT3A R882, JAK2 V617F, and mCAs have been previously explored in the UK Biobank [15], this is the first report of CH in BioVU.